Placebo Controlled Dose-Response Study of Rivoglitazone in Type 2 Diabetes

Clinical trial NCT00575471 · COMPLETED

Trial details

NCT number: NCT00575471
Sponsor: Daiichi Sankyo Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2007-07-01
Primary completion: 2008-03-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.